rfhg_194076.1

Basic information about the TSS

---

TSS ID: rfhg_194076.1 Species: human Chr: chr17		Start: 42998301 End: 42998322 Strand: +
Source datasets	PRJNA401781
Protocol	CAGE|oligo_capping
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2933224,EH38E1864031)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000589037.5:-28 GeneID: 6155 HGNC/MGI_ID: HGNC:10328 UniProt_ID: A0A024R1V4 Nearer transcript ids and distances: ENST00000587478.1:97 ENST00000593262.1:97 ENST00000253788.12:97 NM_000988.5:97 NM_001349922.2:97 NR_146327.2:97 AK124148:97 BC098560:112 ENST00000588830.1:114 AK311792:116 BC002588:127 ENST00000589913.6:149 ENST00000590864.2:368 FJ655906:421 L05094:421 L19527:421 DQ895779:429 KJ892035:429 DQ892563:429 KJ904552:462 BC021886:462 ENST00000586277.5:487 view more...

Gene_name: ribosomal protein L27 Gene_symbol: RPL27 Gene_synonyms: L27 Gene_source: HGNC:10328

TATA-Box annotation

---

Distance to TSS:	38
Nearest PromoterID:	NM_001349921
Entrez ID:	6155
Nearest Unigene:	Hs.514196
Nearest Refseq:	NM_000988
Nearest Ensembl:	ENSG00000131469
Gene Name:	ribosomal protein L27
Gene Alias:	DBA16|L27
Gene Type:	protein-coding
CpG%:	0.047619
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL27 p2@RPL27 p3@RPL27 p4@RPL27 p5@RPL27 p9@RPL27 p10@RPL27
Sample		p1@RPL27	p2@RPL27	p3@RPL27	p4@RPL27	p5@RPL27	p9@RPL27	p10@RPL27
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	357.27	101.69	2.92	44.03	31.75	9.74	4.48
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	298.82	113.50	2.83	57.86	34.60	7.89	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	311.54	112.46	1.74	48.42	30.48	7.33	4.63
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	293.15	108.32	1.87	49.90	41.58	9.15	4.37
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	302.58	127.78	3.15	58.49	37.57	4.95	4.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	277.92	117.45	1.16	55.04	40.31	8.14	5.43
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	479.13	151.43	3.05	67.98	57.30	14.38	6.32
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	422.67	144.12	2.42	62.73	55.95	17.20	5.33
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	384.05	158.15	2.14	68.82	54.07	14.96	7.69
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	205.77	82.31	3.48	45.21	31.88	15.07	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	170.59	83.27	1.62	37.59	32.74	12.13	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	166.28	70.74	1.22	23.58	26.83	6.91	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	239.37	9.03	1.61	1.13	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	233.49	13.38	2.56	1.35	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	307.59	9.22	1.54	1.76	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	202.20	7.80	2.01	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	217.10	9.83	0.87	0.87	0.22	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	210.06	10.55	0.00	2.53	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	196.20	10.66	0.00	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	395.66	12.79	5.42	1.81	0.45	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	219.46	10.69	1.60	1.74	0.13	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	292.94	12.60	3.11	2.76	0.17	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	204.87	9.05	2.33	1.42	0.39	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	227.38	8.74	3.15	0.73	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	289.98	14.45	2.06	2.32	0.00	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	319.04	9.81	1.90	3.48	0.63	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	260.99	10.44	3.30	3.30	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	380.27	12.26	1.89	1.41	0.24	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	275.07	17.77	1.94	1.13	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	278.14	9.05	2.71	0.72	0.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	247.03	14.44	2.09	1.05	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	303.43	12.31	1.76	0.98	0.98	0.78	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	222.64	16.46	2.74	3.38	0.63	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	294.09	17.48	2.64	1.81	0.00	0.49	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	364.63	13.09	2.62	1.50	0.56	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	256.58	12.26	1.92	2.30	0.38	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	334.77	14.92	4.29	1.84	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	243.80	10.28	2.82	0.81	0.40	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	318.45	15.13	2.70	2.97	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	308.48	13.44	2.40	1.92	1.20	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	249.38	12.00	1.65	1.18	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	284.30	16.25	1.46	2.78	0.59	0.44	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	362.10	12.44	4.64	2.32	0.21	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	295.28	13.29	2.45	1.75	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	360.59	17.47	3.61	2.41	1.00	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	367.58	16.75	3.95	1.40	0.00	0.70	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	326.51	14.87	2.64	2.16	0.72	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	433.36	18.78	2.68	0.89	1.79	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	336.32	15.80	1.20	2.63	0.48	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	402.17	15.16	1.82	1.42	0.20	0.40	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	309.28	10.86	8.20	1.84	0.41	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	323.11	13.79	6.23	3.11	0.67	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	181.90	13.99	27.98	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	214.69	12.77	7.81	2.84	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	198.83	13.26	4.64	2.32	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	292.79	11.75	9.23	2.52	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	404.59	11.94	15.15	2.30	0.92	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	213.59	9.72	4.21	0.65	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	194.95	11.24	1.28	0.64	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	449.81	9.74	7.86	1.89	0.00	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	181.90	16.22	5.64	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	181.13	12.90	4.49	1.12	1.12	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	342.34	11.15	5.57	0.80	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	417.23	11.21	3.06	2.04	0.68	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	202.43	8.12	4.55	0.32	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	159.39	12.78	3.90	1.06	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	15.79	15.79	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	187.21	9.26	2.44	0.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	226.12	18.35	4.96	1.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	183.42	17.36	1.88	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	290.78	10.60	3.31	1.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	177.25	11.14	2.47	0.62	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	163.88	11.31	3.36	1.22	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	89.80	15.05	1.11	1.90	1.43	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	99.14	9.63	3.37	1.60	0.64	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	71.37	15.52	0.89	1.15	0.76	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	157.72	12.71	2.24	2.24	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	153.39	8.04	3.35	0.67	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	183.10	12.76	3.19	1.28	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	146.23	15.39	4.40	5.50	1.10	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	117.42	32.97	0.00	4.52	1.35	1.81	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	141.80	12.69	2.09	1.74	0.00	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	79.99	14.08	0.20	0.98	0.20	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	58.94	7.21	0.26	1.03	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	75.27	12.82	0.00	1.12	0.00	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	72.89	9.40	1.18	1.18	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	115.34	16.81	0.08	2.33	0.40	0.48	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	87.14	8.71	0.97	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	50.12	9.06	2.13	0.53	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	50.08	7.23	0.00	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	93.16	4.16	0.42	1.66	0.42	0.83	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	60.03	7.53	0.25	0.75	0.50	1.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	58.90	8.18	0.00	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	55.72	3.35	0.30	0.30	0.00	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	245.31	40.44	0.66	10.17	1.77	3.09	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	243.84	39.80	1.43	6.10	2.87	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	99.44	10.78	3.59	3.59	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	109.74	9.53	0.18	1.98	0.54	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	118.82	8.37	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	156.14	10.89	0.62	0.62	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	132.73	4.46	0.80	1.83	0.11	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	150.86	4.16	1.22	0.24	0.00	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	157.25	12.13	4.49	0.45	1.80	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	133.72	15.63	1.74	3.47	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	121.99	19.26	10.70	2.14	2.14	4.28	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	168.89	10.76	4.18	1.49	0.90	2.09	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	168.20	13.91	2.53	3.79	1.26	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	109.57	17.82	2.64	3.30	1.98	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	147.17	9.42	1.62	2.60	1.30	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	148.06	13.11	1.94	1.94	1.46	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	139.56	17.22	5.34	3.56	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	184.93	13.94	6.03	3.01	1.13	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	164.00	12.34	2.90	2.90	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	125.38	11.28	5.02	5.02	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	92.25	15.81	0.16	2.47	0.82	0.66	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	147.40	15.01	4.09	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	164.51	18.40	1.66	3.77	0.90	1.66	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	176.27	8.57	3.21	3.75	3.21	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	163.81	13.23	1.89	2.83	0.94	1.32	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	119.21	16.57	2.67	2.67	1.34	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	170.70	9.75	2.93	2.93	1.95	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	150.60	15.42	1.82	3.32	1.33	0.66	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	114.07	12.01	1.20	6.00	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	130.99	10.62	3.54	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	137.22	13.21	2.06	2.74	1.37	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	100.68	8.39	0.00	4.19	12.58	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	165.04	12.14	1.94	3.40	2.43	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	177.96	17.83	2.28	5.31	1.90	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	113.87	12.11	6.06	3.63	2.42	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	181.84	14.82	3.99	3.42	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	129.55	13.04	0.64	3.63	1.07	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	137.56	11.36	1.29	3.10	1.55	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	135.13	11.73	2.82	0.94	1.88	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	130.23	10.93	1.61	3.86	1.61	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	131.28	17.12	4.28	3.57	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	140.39	10.53	1.75	4.09	1.17	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	126.15	14.45	1.81	3.31	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	187.70	10.69	5.94	4.75	3.56	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	217.66	13.22	4.58	4.07	2.54	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	178.54	16.05	1.53	3.31	2.29	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	142.96	14.61	3.18	3.81	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	165.28	14.24	3.02	1.29	1.73	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	156.44	13.76	1.69	1.91	1.06	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	131.36	15.37	0.58	2.32	2.03	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	140.77	11.34	1.89	1.89	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	143.25	12.54	1.19	2.37	1.53	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	106.55	9.27	9.27	6.95	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	173.23	8.45	6.34	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	136.79	13.51	1.50	3.00	1.29	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	139.59	15.04	3.61	3.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	161.10	8.75	5.10	4.37	0.73	2.19	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	169.65	12.18	1.61	2.99	1.38	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	122.41	12.75	5.10	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	159.40	26.95	0.51	8.14	2.80	1.27	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	145.54	11.56	0.62	2.68	1.24	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	129.13	13.46	2.14	2.45	2.75	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	179.73	19.12	2.39	1.91	0.48	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	136.15	16.19	0.44	3.55	0.89	1.11	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	125.12	9.15	6.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	144.01	17.17	2.22	2.77	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	141.66	14.03	2.65	2.65	1.32	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	128.30	13.81	5.45	4.00	0.00	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	168.87	18.05	0.25	1.97	0.74	0.86	0.37
Astrocyte - cerebellum, donor2	11580-120F5	291.83	17.63	1.37	1.37	0.51	1.03	0.34
Astrocyte - cerebellum, donor3	11661-122F5	363.28	14.47	0.84	3.78	0.42	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	167.67	10.11	0.70	0.70	0.35	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	225.03	16.18	1.94	3.24	0.49	0.97	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	159.30	12.53	1.94	1.79	0.15	0.75	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	225.36	10.55	2.52	1.38	0.57	0.80	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	255.07	14.91	1.38	3.63	0.63	0.88	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	233.17	14.22	0.91	1.93	0.57	0.91	0.57
Basophils, donor1	12241-129G9	61.72	1.31	1.05	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	72.88	3.25	0.72	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	75.12	2.50	0.44	0.15	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	132.16	15.74	0.43	2.16	0.43	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	113.84	9.14	0.46	0.91	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	129.12	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	377.85	32.01	1.88	7.53	1.88	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	257.65	34.52	1.87	5.20	1.66	1.87	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	521.84	19.34	2.53	3.68	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	171.31	9.90	1.98	1.26	0.18	0.90	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	275.88	40.91	1.34	6.70	1.13	1.85	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	371.71	42.85	1.16	6.52	1.40	1.40	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	246.87	20.47	1.60	3.84	0.00	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	0.00	10.34	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	83.97	1.69	1.13	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	77.58	1.48	1.11	0.19	0.00	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	78.59	0.44	0.22	0.00	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	88.59	1.98	0.57	0.57	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.94	3.79	1.52	0.38	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	56.21	0.66	0.66	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	72.42	1.30	2.75	0.00	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	81.77	1.51	3.62	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	81.25	0.71	1.90	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	63.78	0.84	2.01	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	65.69	1.10	1.93	0.00	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	74.63	0.74	1.98	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.68	1.76	2.55	0.00	0.20	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	78.52	1.60	1.78	0.00	0.00	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	95.54	1.96	4.13	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	59.23	0.70	2.34	0.47	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	94.52	0.53	1.58	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	87.64	3.33	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	62.92	1.04	2.83	0.15	0.15	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	70.84	0.60	2.39	0.20	0.00	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	107.64	2.71	4.37	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	67.95	0.69	3.66	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	83.47	0.68	0.68	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	72.45	0.87	1.75	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	61.06	1.34	3.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	89.32	2.44	4.01	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	86.27	0.84	2.95	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	59.89	0.92	2.76	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	66.23	0.00	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	67.56	1.75	0.88	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	59.29	0.70	2.09	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	69.13	1.12	4.09	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	111.87	2.37	3.88	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	49.14	0.82	2.05	0.00	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	72.78	2.09	1.39	0.46	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	100.68	2.32	4.41	0.46	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	89.58	3.49	4.36	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	112.03	3.23	3.70	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	150.76	7.15	2.17	0.22	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	96.08	4.67	2.18	0.31	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	105.14	2.97	1.40	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	82.72	2.01	1.11	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	153.10	1.28	0.77	0.00	0.00	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	113.30	2.63	0.88	0.44	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	144.01	2.53	1.89	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	193.07	4.06	4.06	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	250.17	4.75	4.07	0.68	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	219.55	6.21	2.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	223.88	2.67	3.73	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	300.73	3.22	6.43	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	190.93	3.51	2.11	1.40	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	222.76	4.71	3.92	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	357.26	0.00	3.95	0.00	0.00	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	190.68	1.64	2.47	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	153.79	0.73	2.18	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	163.06	2.02	3.53	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	169.70	14.14	0.81	1.62	0.00	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	175.38	7.19	0.00	2.80	0.00	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	168.68	3.01	2.01	2.01	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	183.71	2.81	2.25	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	205.54	18.04	0.75	3.38	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	245.55	20.97	0.90	2.48	0.00	0.45	0.45
CD4+ T Cells, donor1	11225-116C1	206.74	3.93	0.36	0.36	0.36	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	258.42	0.61	15.92	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	134.81	3.66	4.27	0.00	0.00	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	158.76	4.08	4.08	0.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	148.91	4.49	2.25	0.45	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	117.00	3.16	1.72	0.00	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	296.31	4.74	6.64	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	403.13	4.92	8.43	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	210.96	0.00	19.78	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	106.07	3.47	1.73	0.58	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	133.20	4.74	4.58	0.17	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	122.36	4.67	2.90	0.16	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	206.67	3.59	3.14	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	185.18	2.80	5.24	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	190.51	3.08	2.64	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	180.88	3.79	1.69	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	142.11	4.78	4.36	0.83	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	140.00	3.01	3.34	0.33	0.33	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	218.64	2.45	1.63	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	299.60	3.22	6.43	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	247.47	1.79	12.55	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	152.24	4.26	2.60	1.11	0.00	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	120.87	6.07	2.17	0.22	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	100.66	4.41	1.47	0.63	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	221.45	5.56	9.10	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	211.43	4.77	1.73	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	224.44	4.36	4.79	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	362.74	3.46	5.44	0.00	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	363.74	10.16	0.92	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	325.23	5.58	5.58	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	237.60	4.71	1.94	0.28	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	285.39	3.93	2.21	0.00	0.00	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	183.26	1.54	1.54	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	240.30	4.66	5.73	0.36	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	306.08	4.15	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	162.39	2.95	0.98	0.98	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	148.67	2.63	3.75	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	198.71	5.05	5.30	0.50	0.25	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	185.35	28.67	1.38	5.51	0.46	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	150.50	26.84	1.20	7.43	0.96	0.48	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	208.75	18.88	2.46	7.66	0.55	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	248.27	26.42	2.10	8.11	1.20	0.90	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	149.27	22.08	1.44	5.52	0.24	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	152.12	24.10	1.14	5.91	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	261.61	38.89	1.74	10.21	0.43	0.00	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	227.41	28.69	1.32	10.53	0.79	0.53	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	247.18	33.77	1.88	11.96	1.17	0.70	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	280.14	49.51	0.91	16.60	3.02	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	264.65	39.51	0.87	14.23	1.45	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	218.21	38.90	1.87	18.12	1.07	0.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	54.72	11.82	0.44	4.38	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	59.66	10.93	1.37	3.64	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.18	8.95	0.00	3.73	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	132.90	22.69	1.44	6.12	0.72	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	140.98	26.76	0.58	4.60	0.58	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	145.42	15.56	0.00	4.24	0.94	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	187.29	31.06	0.63	12.36	1.27	0.00	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	171.31	31.37	0.92	10.46	0.31	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	169.59	35.26	0.96	7.69	0.00	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	164.08	32.13	1.15	12.24	2.29	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	163.95	32.71	0.39	12.22	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	151.28	21.18	0.00	9.83	1.51	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.98	16.86	0.00	2.41	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	54.56	10.49	0.00	0.70	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	50.09	10.02	0.00	3.01	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	38.38	5.48	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	182.32	15.81	1.98	2.47	1.48	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	165.11	19.26	0.32	3.26	0.63	0.84	0.21
Chondrocyte - de diff, donor1	11261-116G1	188.93	17.33	1.39	1.04	1.73	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	87.07	8.88	1.07	1.78	1.07	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	102.86	8.65	0.91	0.91	0.23	0.23	0.34
Chondrocyte - re diff, donor2	11339-117F7	73.41	14.32	0.00	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	84.92	6.87	1.62	1.62	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	172.37	14.34	1.61	1.72	0.23	0.00	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	175.07	13.25	4.49	2.35	0.86	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	157.35	13.54	1.15	2.74	0.27	0.27	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	70.88	2.93	0.37	0.18	0.28	0.64	0.18
Corneal Epithelial Cells, donor1	11526-119I5	106.93	15.59	0.22	1.76	0.22	1.10	0.00
Corneal Epithelial Cells, donor2	11606-120I4	129.69	15.93	2.28	4.55	1.14	2.28	2.28
Corneal Epithelial Cells, donor3	11687-122I4	277.36	37.58	1.28	7.16	1.79	1.28	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	40.45	5.45	0.50	1.16	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	74.12	5.05	0.00	0.63	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	10.35	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.80	4.21	0.65	0.97	0.00	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	153.74	3.76	1.71	0.34	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	197.17	6.53	2.61	0.00	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	156.80	3.87	0.48	0.48	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	119.07	35.86	0.17	7.50	1.33	1.33	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	198.92	27.58	0.00	6.45	3.52	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	118.21	24.89	0.85	4.81	1.70	2.26	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	102.62	16.12	2.36	2.75	2.36	1.18	0.79
Endothelial Cells - Artery, donor1	11264-116G4	171.03	27.92	1.75	3.78	2.33	2.62	1.16
Endothelial Cells - Artery, donor2	11341-117F9	105.40	25.17	1.65	5.65	1.41	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	150.77	29.80	1.05	7.19	0.88	1.40	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	94.42	13.52	1.33	3.77	0.89	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	43.51	9.13	0.30	1.83	0.61	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.08	7.61	0.28	1.69	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	132.52	9.81	0.59	2.38	0.59	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	165.57	34.88	1.56	12.50	2.60	2.60	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	81.39	6.81	1.70	1.42	0.00	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	194.46	38.01	0.00	7.20	2.80	0.80	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	108.49	22.54	3.14	4.19	1.57	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	148.72	29.07	0.50	6.21	1.24	1.12	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	152.74	13.90	1.09	1.74	0.65	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	156.45	22.47	1.22	3.42	0.61	1.34	0.98
Endothelial Cells - Vein, donor1	11267-116G7	203.61	31.85	1.14	10.24	2.28	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	59.37	27.24	0.70	11.87	0.70	0.00	2.10
Endothelial Cells - Vein, donor3	11416-118F3	145.23	29.36	2.04	7.22	1.73	0.94	0.47
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	18.15	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	28.53	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	151.24	17.84	0.49	3.66	0.49	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	143.53	12.48	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	16.27	0.00	32.54	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	159.28	8.21	3.28	0.82	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	180.87	25.51	3.61	6.02	1.75	0.55	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	976.67	45.72	3.58	9.86	3.03	0.43	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	156.69	29.71	1.21	5.34	1.21	0.49	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	73.15	30.30	0.27	5.19	1.50	0.27	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	115.17	12.66	2.00	2.11	0.84	0.21	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	185.50	17.13	0.26	1.32	1.05	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	378.38	27.24	2.99	5.65	1.33	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	200.50	25.40	3.63	6.80	1.81	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	119.00	18.95	0.76	0.76	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	136.11	22.87	2.21	5.99	1.58	0.47	0.47
Fibroblast - Cardiac, donor4	11452-119A3	54.26	15.16	0.00	2.73	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	181.35	18.40	1.52	2.28	0.89	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	219.51	25.47	2.88	2.73	1.36	0.91	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	104.91	10.85	0.27	0.54	0.27	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	114.76	12.94	0.43	1.73	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	197.75	14.65	0.00	2.93	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	54.66	9.92	0.00	2.08	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	101.08	4.41	0.00	1.36	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	264.13	23.95	1.64	6.34	1.41	1.64	0.47
Fibroblast - Dermal, donor2	11346-117G5	174.05	32.55	0.94	4.25	1.42	2.83	0.94
Fibroblast - Dermal, donor3	11418-118F5	206.59	20.43	1.93	4.35	1.21	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	260.46	13.23	2.37	2.37	0.34	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	373.85	25.64	2.44	2.79	1.22	1.57	1.57
Fibroblast - Dermal, donor6	11458-119A9	424.25	22.90	1.30	4.39	0.65	2.60	0.49
Fibroblast - Gingival, donor1	11237-116D4	201.36	16.87	0.21	1.04	0.83	1.04	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	151.96	7.60	1.05	0.79	0.52	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	247.23	13.44	3.16	2.64	0.26	1.58	0.26
Fibroblast - Gingival, donor3	11394-118C8	93.30	4.06	0.77	1.35	0.10	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	88.31	7.27	0.00	0.00	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	83.70	5.64	1.94	0.70	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	176.16	11.54	0.31	1.71	1.25	1.25	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	145.10	11.09	0.68	1.35	0.54	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	10.59	0.00	1.41	1.06	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	181.78	11.70	0.73	1.02	0.44	0.88	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	160.35	13.23	0.95	2.05	0.82	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	307.80	18.43	1.10	4.61	0.55	0.77	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	102.42	3.82	0.44	0.59	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	149.53	14.95	1.36	2.72	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	82.07	8.95	2.98	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	135.70	10.34	2.32	1.90	0.63	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	109.96	14.99	0.00	0.83	0.83	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	141.26	15.38	0.00	1.40	0.00	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	69.69	7.28	0.28	1.12	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	148.18	17.86	0.00	2.84	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	227.67	11.98	0.00	0.00	3.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	119.13	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	278.35	21.14	0.97	2.52	0.39	1.55	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	219.79	13.50	1.97	1.52	0.61	1.06	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	81.09	18.67	0.00	2.14	1.22	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	137.77	8.01	1.14	0.38	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	156.05	10.26	3.51	2.43	0.00	0.27	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	90.58	5.45	1.39	0.70	0.58	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	206.47	48.41	0.66	9.84	2.43	1.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	116.23	15.65	0.20	1.02	0.41	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	217.17	16.04	0.00	2.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	254.61	17.40	1.19	5.14	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	93.67	9.33	0.20	0.99	0.60	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	80.99	7.82	0.00	0.53	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	109.97	12.81	0.00	0.99	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	135.69	16.25	0.90	0.90	0.90	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	153.62	8.85	0.32	0.86	0.32	0.76	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	98.95	6.83	0.25	0.51	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	92.38	8.70	0.66	1.15	0.82	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	106.07	14.04	0.20	2.61	0.40	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	165.76	10.05	0.20	0.50	0.50	0.40	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	127.54	7.56	0.91	0.30	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	89.23	8.37	0.50	0.50	0.17	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	272.67	6.33	0.68	0.68	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	101.49	11.82	0.00	0.99	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	194.51	13.74	0.75	0.96	0.75	0.85	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	138.15	15.01	0.00	1.52	1.35	0.84	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	332.77	7.53	5.33	1.57	0.47	0.94	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	44.32	22.16	22.16	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	139.44	8.72	4.36	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	153.77	41.43	1.04	8.84	1.91	1.39	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	88.74	20.82	0.26	6.25	0.26	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	91.73	29.38	0.00	8.43	1.53	0.26	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	466.22	101.05	4.59	37.51	6.12	3.06	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	576.82	116.13	9.57	51.05	14.04	3.83	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	852.08	79.87	8.56	27.96	5.13	3.42	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	245.98	12.96	4.14	1.38	0.28	0.83	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	195.45	12.56	3.65	4.11	0.00	1.37	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	497.31	45.37	4.95	15.06	1.39	1.19	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	248.47	14.01	3.97	2.38	0.26	0.26	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	168.62	11.09	1.96	1.30	0.65	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	550.13	69.43	4.42	26.09	5.31	4.42	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	189.94	26.71	2.26	6.36	2.12	1.55	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	148.88	20.07	1.60	4.93	1.85	0.99	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	185.35	40.56	1.34	8.60	2.15	0.81	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	138.88	13.75	0.74	1.98	0.74	0.87	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	153.10	15.09	0.83	3.60	0.55	1.11	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	176.67	26.84	3.05	7.93	1.42	0.81	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	97.20	10.72	1.60	1.60	0.46	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	108.12	10.46	0.62	1.37	0.12	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	112.35	12.68	1.09	1.31	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	126.17	11.52	1.18	1.18	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	87.27	7.79	1.27	0.48	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	122.43	16.09	0.67	1.12	0.00	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	102.23	10.08	2.02	1.61	0.60	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	105.69	11.87	1.53	2.37	0.68	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	98.43	15.96	0.35	3.19	0.27	1.06	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	122.99	9.37	1.04	0.62	0.31	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	93.41	11.78	0.68	1.37	0.34	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	129.80	8.41	0.55	1.22	0.22	0.66	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	100.75	15.22	1.08	2.50	0.50	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	94.54	15.31	0.61	1.43	1.02	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	125.85	7.84	2.06	0.83	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	84.39	5.65	1.15	0.69	0.23	0.12	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	103.06	13.17	1.33	1.67	0.17	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	101.84	7.49	0.66	1.10	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	152.76	6.52	1.60	1.48	0.00	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	108.76	15.24	1.13	1.78	0.65	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	108.08	6.41	1.60	0.96	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	85.75	5.97	0.85	0.66	0.00	0.19	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	113.73	11.07	0.79	0.95	0.47	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	108.56	11.86	1.52	2.43	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	120.11	9.20	0.63	2.20	0.21	0.31	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	101.43	6.81	1.10	1.98	0.00	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	109.69	8.42	0.56	0.84	0.84	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	72.87	9.26	1.11	1.94	0.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	99.74	17.92	2.41	1.60	1.07	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	95.48	18.82	0.46	4.28	0.77	0.00	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	109.33	11.40	0.39	2.85	0.39	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	96.50	11.66	0.27	1.36	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	94.76	8.11	2.03	0.55	0.00	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	85.97	10.09	1.32	0.44	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	28.76	1.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	85.48	9.10	0.40	0.66	0.26	0.40	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	83.93	7.26	1.41	1.61	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.21	2.54	0.25	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	252.61	43.59	1.99	8.36	3.98	1.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	194.60	24.19	1.39	5.24	0.92	1.39	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	199.88	26.19	1.43	6.14	1.43	1.64	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	405.87	135.50	4.07	40.06	9.39	4.69	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	415.92	131.11	2.54	33.06	7.35	3.11	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	230.14	47.50	6.46	12.91	2.31	2.31	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	314.30	84.14	4.95	24.75	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	285.46	66.53	3.87	21.66	5.80	0.39	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	189.33	81.83	4.81	24.07	14.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	156.49	46.95	3.48	22.60	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	266.89	54.68	4.56	12.69	2.93	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	243.79	50.65	6.18	16.06	3.29	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	309.90	39.99	6.66	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	251.96	32.44	1.40	7.27	1.40	0.84	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	216.04	32.36	3.27	9.48	0.65	3.27	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	186.22	25.17	4.19	3.36	0.00	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	221.70	25.45	3.18	2.86	0.32	1.27	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	237.08	32.95	1.70	5.09	0.00	1.02	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	373.78	31.32	12.53	6.26	0.00	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	239.96	21.19	7.45	4.58	0.57	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	195.35	21.31	4.14	2.66	0.59	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	272.76	28.80	6.78	10.16	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	265.51	36.45	11.60	6.21	2.90	2.07	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	235.19	31.07	2.30	4.14	2.07	1.15	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	321.38	26.34	10.54	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	179.52	18.07	3.08	1.54	1.54	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	214.16	20.54	3.91	1.96	0.33	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	321.04	18.73	5.35	2.01	2.68	0.67	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	207.27	13.87	3.08	0.77	0.39	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	182.81	21.57	1.03	5.82	3.42	1.37	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	260.90	24.85	9.94	0.00	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	293.02	13.21	6.13	0.94	0.00	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	204.58	12.07	3.62	0.00	0.60	0.60	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	346.92	15.26	7.63	1.53	0.00	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	275.20	15.16	7.98	1.99	0.00	1.20	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	280.23	14.80	7.40	1.48	0.00	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	275.04	9.44	25.97	2.36	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	273.64	16.34	4.67	2.92	0.00	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	198.37	8.34	4.39	0.88	0.44	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	169.54	18.65	5.09	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	179.67	22.68	4.78	4.18	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	222.73	16.50	2.91	1.94	1.94	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	183.75	11.41	4.57	4.57	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	64.04	6.24	1.25	2.08	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	165.29	22.49	1.12	5.62	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	140.82	8.56	2.54	3.17	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	204.69	11.28	3.34	2.51	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	236.38	25.41	1.62	4.53	1.16	1.28	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	177.58	23.63	1.35	6.25	1.52	2.36	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	174.04	21.16	1.14	3.87	0.46	1.59	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	237.31	27.76	1.86	5.68	0.66	1.64	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	168.49	18.48	1.07	4.73	0.43	1.29	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	164.69	21.53	1.08	4.95	1.72	1.08	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	223.42	25.78	1.25	5.60	1.87	1.49	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	192.31	18.70	0.69	4.63	0.86	1.72	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	167.88	21.79	1.28	1.28	0.00	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	149.42	10.07	0.56	3.36	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	174.42	29.00	0.87	2.16	1.30	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	89.89	47.59	2.64	7.93	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	120.63	18.69	0.00	2.82	1.06	1.06	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	123.51	16.71	0.73	0.73	2.91	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	263.83	35.84	1.40	9.27	1.92	1.75	0.52
Hepatocyte, donor1	11523-119I2	88.37	2.42	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	68.95	2.15	1.08	1.08	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	92.03	6.75	1.23	0.61	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	125.97	26.76	3.26	3.26	0.00	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	142.80	21.32	1.05	1.75	0.00	0.70	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	170.27	14.96	0.14	2.47	0.41	0.96	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	404.35	15.92	0.00	9.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	200.26	13.35	6.68	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	189.58	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	285.18	38.76	1.38	12.46	6.92	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	187.70	32.53	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	59.34	0.00	11.87	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	322.93	30.75	2.56	7.69	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	228.54	41.14	0.00	0.00	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	230.65	45.48	3.25	1.62	8.12	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	290.11	40.02	1.67	10.00	3.33	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	196.05	18.15	3.63	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	252.78	39.70	2.65	13.23	5.29	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	347.01	31.04	0.00	11.09	8.87	4.43	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	188.58	20.95	0.00	15.71	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	314.93	28.34	3.15	11.34	3.78	1.89	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	360.36	43.31	0.00	7.73	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	248.79	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	294.59	27.78	3.23	9.04	1.94	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	321.99	37.03	1.61	16.10	3.22	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	179.22	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	359.36	39.11	1.63	8.96	3.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	156.17	42.40	0.42	18.47	4.20	1.68	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	244.33	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	274.06	22.50	4.02	11.25	2.41	1.61	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	350.85	36.01	3.69	7.39	2.77	3.69	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	150.81	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	318.63	28.79	2.36	8.50	1.42	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	340.12	35.37	4.53	11.79	0.91	2.72	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	259.34	29.06	4.30	10.76	1.08	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	357.00	43.20	5.08	15.25	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	312.18	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	225.74	28.70	0.64	9.57	3.19	1.91	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	377.29	36.45	3.65	20.05	3.65	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	252.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	249.92	27.85	4.28	7.85	2.14	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	328.51	53.09	0.00	9.95	6.64	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	208.49	20.85	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	287.05	24.38	1.85	8.64	2.16	1.54	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	328.38	28.10	0.00	14.05	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	257.74	18.86	0.00	15.72	3.14	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	262.16	31.29	0.70	6.26	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	261.15	30.98	2.21	13.28	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	210.73	25.94	0.00	16.21	12.97	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	157.82	20.05	1.74	4.36	2.62	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	299.22	22.50	0.00	2.25	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	191.65	34.85	3.48	6.97	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	179.22	21.34	2.13	8.53	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	285.40	29.09	0.00	6.93	1.39	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	233.67	34.20	2.85	5.70	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	219.98	34.98	1.84	7.36	0.00	4.60	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	314.63	24.20	3.03	3.03	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	155.22	6.21	0.00	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	154.38	7.40	0.00	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	84.37	26.44	0.24	5.88	2.12	0.49	0.24
Keratinocyte - epidermal, donor2	11349-117G8	57.98	21.08	0.59	2.93	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	245.92	25.94	1.33	4.16	1.51	0.95	0.38
Keratinocyte - oral, donor1	11251-116E9	185.94	11.58	1.25	1.14	0.00	0.79	0.34
Keratocytes, donor1	11527-119I6	84.58	11.35	0.69	1.72	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	240.22	8.20	1.17	2.34	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	80.42	7.51	0.40	0.00	0.00	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	191.22	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	248.11	26.97	3.24	6.47	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	110.72	5.19	0.00	0.92	0.00	0.35	0.12
Lens Epithelial Cells, donor3	11690-122I7	113.73	20.99	0.10	4.44	0.91	0.61	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	99.72	12.92	0.71	1.78	0.83	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	100.47	9.21	0.56	1.67	0.84	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	130.97	9.92	1.42	1.42	0.47	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	123.67	12.91	1.61	1.08	0.54	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	100.22	11.35	0.63	1.26	0.63	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	135.95	12.72	2.48	2.70	0.65	0.97	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	89.88	9.44	1.23	2.87	0.82	1.64	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	111.24	9.35	1.52	3.03	0.25	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	128.51	10.56	1.97	1.97	0.56	0.99	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	115.89	8.70	1.19	1.58	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	116.14	12.99	1.55	2.33	0.78	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	123.86	11.11	1.11	1.48	0.74	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	112.19	11.85	0.70	2.09	0.00	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	102.80	12.16	0.24	3.58	0.48	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	114.82	10.44	1.37	2.06	0.55	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	106.86	11.39	1.54	2.16	1.23	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	113.47	9.98	1.25	2.18	0.94	1.87	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	126.81	13.72	1.28	2.74	1.10	0.55	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	107.29	14.81	0.99	1.65	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	105.73	10.84	2.05	2.34	0.88	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	126.21	15.43	1.49	2.99	0.50	1.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	125.61	14.55	1.94	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	135.73	9.96	0.81	1.89	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	146.84	12.11	1.36	2.42	0.45	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	124.94	11.92	3.11	1.04	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	95.06	12.56	1.68	2.72	0.84	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	121.35	11.28	1.50	1.80	0.45	0.45	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	128.63	9.63	0.69	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	96.90	10.72	0.38	1.88	1.32	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	123.74	9.65	1.38	2.76	0.74	0.85	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	106.12	15.99	1.94	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	80.38	9.26	0.33	1.65	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	114.85	9.42	0.99	2.35	0.37	0.50	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	103.29	14.81	1.85	1.85	0.37	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	83.02	8.40	0.49	2.96	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	119.34	11.41	1.51	2.61	0.82	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	95.53	9.97	1.29	1.61	0.64	1.29	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	99.82	11.26	0.91	1.52	0.91	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	116.73	10.92	0.70	0.84	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	115.56	11.02	1.78	3.56	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	92.59	6.79	1.45	3.39	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	126.82	12.29	0.93	3.89	0.16	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	136.80	20.41	1.07	2.51	1.07	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	114.01	9.15	0.65	1.96	0.65	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	132.31	11.54	1.65	3.30	0.47	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	89.72	14.48	0.62	2.85	0.74	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	105.01	11.01	0.51	2.56	1.54	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	150.37	10.44	0.90	2.09	0.60	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	70.25	11.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	121.97	12.27	2.30	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	107.62	11.88	2.23	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	96.90	7.62	3.39	0.85	1.27	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	109.72	9.14	2.11	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	99.00	10.27	5.60	4.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	81.41	8.76	9.27	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	139.17	5.95	8.33	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	66.50	9.95	0.68	2.49	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	92.19	8.43	5.82	0.87	0.29	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	143.16	8.10	2.70	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.59	10.84	0.54	1.76	0.14	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	94.49	9.24	2.05	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	120.32	9.88	1.41	1.41	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	113.94	9.33	1.33	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	103.41	4.58	5.60	0.51	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	120.06	8.80	2.93	1.60	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	113.18	9.07	3.59	1.13	0.57	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	120.87	7.36	2.45	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	136.99	10.60	0.00	3.26	0.00	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	113.08	8.75	2.92	1.46	0.00	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	114.07	8.97	5.32	1.40	0.84	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	111.28	13.39	3.09	1.03	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	108.57	11.61	4.94	1.74	0.00	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	100.14	7.17	2.39	1.79	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	121.16	10.51	1.11	0.55	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	92.61	9.54	1.77	3.18	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	96.25	6.27	4.06	2.21	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	117.43	14.97	2.30	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	87.50	11.90	1.15	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	109.83	13.02	5.66	1.70	0.00	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	139.48	13.13	2.46	0.82	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	97.61	11.75	1.81	4.52	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	103.41	8.62	4.31	2.15	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	137.43	10.46	2.99	4.48	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	86.58	7.06	3.72	1.49	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	79.26	8.18	1.72	1.29	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	147.28	9.42	2.57	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	111.95	9.00	4.00	2.67	1.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	88.69	10.26	1.81	2.41	0.00	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	109.49	13.51	2.84	2.84	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	113.43	11.00	1.03	2.75	0.00	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	72.46	5.90	4.29	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	119.18	11.45	2.02	4.04	0.67	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	93.34	12.96	3.70	2.22	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	63.96	11.63	1.16	1.16	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	130.10	14.81	2.12	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	99.24	12.40	2.40	1.20	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	85.04	11.63	2.18	2.18	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	133.37	7.67	1.53	3.83	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	101.62	9.87	3.95	2.47	0.49	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	85.62	11.29	2.82	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	121.18	11.56	3.02	1.51	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	91.93	13.97	0.45	1.35	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	74.01	8.61	1.72	1.72	1.72	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	136.27	10.69	4.01	4.01	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	72.73	8.99	2.74	3.13	0.39	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	74.55	7.26	6.60	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	116.76	10.38	1.04	1.56	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	83.14	5.69	3.06	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	78.83	10.06	2.24	3.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	101.14	11.04	1.32	1.32	1.32	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	104.14	10.03	3.09	2.70	0.77	0.77	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	80.51	9.11	2.53	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	112.95	9.13	1.44	2.88	0.48	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	95.81	12.32	0.80	2.39	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	82.64	6.08	3.65	1.22	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	134.19	13.83	1.38	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.60	12.16	3.04	1.90	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	98.12	9.81	2.07	0.00	1.03	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	175.95	12.09	1.81	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	100.77	9.82	3.17	1.27	0.63	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	106.08	9.60	0.53	1.07	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	141.37	10.92	2.87	1.15	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	86.39	9.26	3.09	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	90.54	14.85	1.41	2.12	0.71	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	153.79	15.89	1.70	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	92.36	9.98	1.25	2.91	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	60.29	13.31	2.35	3.92	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	134.87	20.46	0.42	2.09	0.00	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	100.83	16.26	1.39	2.79	0.93	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	98.35	17.40	2.01	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	132.06	14.44	2.14	2.67	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	106.68	11.72	4.04	2.42	0.40	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	88.11	20.19	0.00	0.92	0.00	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	163.60	13.34	0.00	2.67	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	123.66	15.96	2.28	2.28	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	95.86	18.41	2.30	3.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	215.04	22.98	3.28	4.38	1.09	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	97.55	19.15	1.34	4.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	79.03	33.79	0.26	6.50	1.04	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	186.33	28.51	1.99	3.32	1.99	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	106.01	31.18	0.00	6.24	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	63.36	2.51	0.23	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	45.69	4.40	0.00	0.37	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	69.08	2.10	1.70	0.39	0.00	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	123.20	44.07	0.53	12.74	4.78	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	109.33	13.63	0.48	2.06	0.95	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	192.64	17.10	1.11	6.25	1.81	0.69	0.28
Mammary Epithelial Cell, donor1	11273-116H4	103.73	16.34	0.30	3.19	0.10	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	110.90	18.24	0.58	6.37	0.58	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	195.05	31.93	0.75	9.73	1.00	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	26.44	2.03	0.00	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	62.72	4.33	0.00	0.11	0.11	0.00	0.00
Mast cell, donor2	11565-120D8	64.49	0.59	1.19	0.00	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	84.87	1.80	0.68	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	49.46	1.77	0.18	0.00	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	79.73	3.11	0.33	0.00	0.00	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	64.21	8.17	1.17	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	50.82	3.79	0.57	0.46	0.23	0.00	0.11
Mast cell, expanded, donor8	11941-126A6	38.16	3.35	1.00	0.33	0.50	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	89.65	16.72	0.30	2.59	0.30	0.90	0.40
Melanocyte - dark, donor2	11582-120F7	192.77	9.69	1.38	3.46	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	138.58	27.09	0.07	2.83	0.51	0.29	0.43
Melanocyte - light, donor1	11274-116H5	39.73	9.64	0.24	1.65	0.24	0.47	0.24
Melanocyte - light, donor2	11351-117H1	42.31	4.09	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	78.05	5.20	0.87	6.07	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	159.10	21.66	0.31	2.71	0.62	0.62	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	117.53	17.48	0.81	2.42	0.54	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	74.73	9.91	0.54	1.61	1.07	0.00	0.00
Meningeal Cells, donor1	11493-119E8	167.85	22.83	0.00	2.11	1.36	1.61	0.87
Meningeal Cells, donor2	11573-120E7	320.87	23.33	0.44	1.32	0.44	1.76	0.44
Meningeal Cells, donor3	11654-122E7	225.76	29.83	0.57	5.46	2.20	2.53	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	279.17	18.82	0.57	4.28	0.00	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	85.94	16.81	0.30	3.72	1.11	0.40	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	28.91	2.63	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	187.07	18.31	0.00	2.62	0.00	3.92	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	265.51	32.29	0.72	8.61	3.59	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	80.47	8.05	0.42	1.48	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	140.74	8.04	1.51	2.01	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	214.26	30.99	0.22	4.40	1.32	2.42	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	314.15	31.42	1.46	10.23	0.73	2.92	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	273.76	28.03	1.64	4.71	2.05	1.23	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	109.56	8.86	0.69	0.14	0.00	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	50.93	11.15	0.00	1.12	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	133.15	6.58	0.53	1.32	0.66	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	260.54	20.18	1.78	6.23	0.89	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	56.05	14.01	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	568.68	33.94	1.92	10.89	0.64	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	355.15	49.27	2.48	10.28	3.19	1.06	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	145.42	6.57	0.31	0.31	0.94	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	568.94	60.23	2.90	6.53	1.45	2.90	0.73
Mesothelial Cells, donor1	11247-116E5	111.11	14.85	0.00	1.33	1.86	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	75.07	21.52	1.50	6.51	2.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	73.20	8.67	1.01	1.37	0.72	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	28.36	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	95.55	2.22	1.72	0.99	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.53	3.24	0.88	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	81.52	2.48	2.17	0.00	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.29	3.11	0.00	0.41	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	79.33	1.50	1.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	40.03	4.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	66.05	2.44	1.63	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	37.22	3.56	0.40	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	73.45	1.77	3.54	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	55.47	7.22	0.00	1.14	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	55.82	2.97	1.06	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	44.71	1.49	0.60	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	64.73	4.27	1.00	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.50	2.85	0.24	0.95	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	57.79	4.60	0.23	0.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	46.06	3.16	0.21	1.05	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	49.53	2.24	0.41	0.61	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	64.36	4.08	1.07	0.64	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	31.57	2.22	0.00	0.67	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	46.43	2.63	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	26.36	2.53	0.00	0.51	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	58.71	2.99	0.82	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	33.53	1.76	0.29	0.29	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	56.22	3.36	1.44	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	42.82	2.80	0.00	0.40	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	52.56	6.51	0.00	1.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	2.04	0.00	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	46.86	3.94	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	27.59	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	62.48	5.45	0.99	0.50	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	2.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	50.94	2.05	0.34	0.68	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.01	2.19	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.41	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	63.12	3.65	1.12	1.12	0.00	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	31.59	2.91	0.00	1.25	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	1.17	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	40.12	4.52	0.00	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	55.93	2.92	1.67	0.83	0.42	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	7.39	0.92	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.96	4.55	0.00	0.57	0.57	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	39.11	2.07	0.41	0.69	0.00	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	46.39	4.66	0.78	0.52	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.05	5.15	0.43	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.88	1.27	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.69	3.20	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	43.70	2.10	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	23.17	1.70	0.00	0.42	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	37.27	5.10	0.32	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	48.21	2.43	0.00	0.88	0.44	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.72	1.90	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.30	3.13	0.00	0.57	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	57.27	4.42	0.00	0.98	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	18.25	1.96	0.00	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	33.23	1.47	1.47	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	45.84	4.04	0.00	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.84	1.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.20	1.49	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	71.57	7.53	3.77	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	49.90	5.35	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	82.47	3.94	3.29	0.66	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	103.09	5.26	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	67.61	2.97	0.99	0.00	0.00	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	76.37	1.86	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	117.92	3.76	1.50	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	63.39	2.93	0.80	0.27	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	55.87	2.60	0.45	0.11	0.00	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	52.31	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	68.15	5.50	0.37	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	63.78	0.00	3.11	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	56.65	4.81	0.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	100.46	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	75.75	1.01	0.00	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	69.15	2.95	0.42	1.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	107.59	1.36	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	83.29	1.27	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	92.32	3.24	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	119.32	1.51	4.53	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	81.56	9.79	3.26	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	4.75	4.75	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	130.77	26.50	0.22	2.80	2.59	1.08	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	122.29	5.23	0.52	2.61	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	164.87	11.35	0.67	2.00	2.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	173.21	11.27	0.42	1.67	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	479.92	11.41	3.23	2.28	1.33	0.57	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	292.04	17.55	3.19	6.38	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	108.79	3.40	0.68	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	112.10	5.51	1.84	1.84	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	107.98	6.28	2.51	0.84	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	243.36	13.48	1.39	2.09	1.63	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	149.98	6.22	0.81	1.08	0.27	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	86.83	4.84	0.84	0.84	0.42	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	111.35	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	134.51	4.96	1.49	1.99	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	195.15	6.50	0.81	1.08	0.27	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	160.26	6.12	0.91	1.36	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	122.31	4.74	0.16	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	100.42	6.20	2.00	0.91	0.18	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	128.90	10.08	1.06	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	107.45	4.80	0.00	1.20	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	349.18	6.24	2.63	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	108.80	4.39	0.98	1.14	0.16	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	114.47	6.17	2.12	0.35	0.00	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	144.87	4.92	2.81	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	142.05	3.22	1.38	0.92	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	153.92	8.68	1.93	1.29	0.64	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	368.69	3.45	7.24	0.69	1.38	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	126.42	10.11	5.06	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	87.55	6.02	0.45	1.34	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	153.27	5.50	0.42	0.85	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	188.22	5.22	0.71	1.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	175.13	12.45	1.72	1.29	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	99.31	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	135.95	3.33	0.33	1.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	72.14	8.57	0.00	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	130.55	8.33	1.59	2.38	0.79	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	154.16	4.64	1.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	253.13	7.57	3.78	1.51	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	108.85	6.84	2.28	1.63	0.98	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	91.95	3.49	0.87	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	128.90	9.50	1.36	0.90	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	110.24	11.46	1.76	0.88	0.00	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	134.96	6.65	2.66	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	150.80	3.97	1.98	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	107.57	5.36	0.77	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	187.82	3.93	0.30	0.30	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	80.01	7.51	1.11	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	126.04	6.78	2.71	4.07	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	15.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	162.18	2.44	1.22	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	118.97	6.29	0.00	2.20	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	128.02	1.51	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	114.72	6.33	1.58	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	234.66	6.80	2.27	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	141.62	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	169.45	33.54	0.87	9.44	2.36	1.24	0.37
Myoblast, donor2	11322-117D8	146.53	14.77	2.69	3.07	0.19	0.58	0.19
Myoblast, donor3	11398-118D3	109.81	18.33	0.50	3.87	1.18	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	182.12	14.30	1.61	1.61	0.00	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	143.61	3.38	0.31	0.92	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	150.78	2.11	7.24	0.30	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	118.53	1.84	1.47	0.18	0.18	0.18	0.00
Neural stem cells, donor1	11275-116H6	145.18	17.42	0.36	1.45	0.73	0.00	0.00
Neural stem cells, donor2	11352-117H2	90.51	7.70	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	194.58	19.34	1.14	1.14	0.00	0.00	1.14
Neurons, donor2	11574-120E8	138.26	15.41	0.66	2.20	0.66	0.22	0.66
Neurons, donor3	11655-122E8	224.45	9.87	6.58	0.82	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	11.14	0.93	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	11.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	115.65	4.63	1.19	1.66	0.24	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	78.47	2.28	1.30	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	183.71	5.82	1.40	1.40	0.20	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	121.00	5.09	0.83	1.38	0.28	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	187.16	11.00	5.21	1.88	1.01	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	147.22	7.26	1.36	1.25	0.57	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	119.90	7.01	0.78	0.78	0.39	0.10	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	172.12	21.67	0.60	1.81	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	96.99	8.72	0.43	2.13	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	125.74	2.29	8.00	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	939.13	5.59	3.72	4.97	0.00	0.62	1.24
Osteoblast, donor1	11277-116H8	575.37	38.89	1.17	11.53	0.78	0.59	0.39
Osteoblast, donor2	11354-117H4	106.75	16.15	0.00	1.40	1.40	2.11	0.00
Osteoblast, donor3	11426-118G4	209.54	23.99	1.78	4.62	1.42	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	133.01	9.94	0.59	0.76	0.25	0.17	0.00
Pericytes, donor1	11491-119E6	65.20	5.34	0.00	0.67	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	218.22	11.32	1.58	0.68	0.00	0.45	0.23
Pericytes, donor3	11652-122E5	278.73	21.16	3.66	3.66	1.63	1.22	0.00
Perineurial Cells, donor1	11499-119F5	196.88	17.07	0.23	1.58	0.34	1.47	0.34
Perineurial Cells, donor2	11579-120F4	122.28	13.71	0.28	2.94	1.01	0.55	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	119.53	2.23	0.32	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	96.23	1.47	4.16	0.00	0.00	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	85.16	1.68	1.04	0.00	0.00	0.00	0.13
Placental Epithelial Cells, donor1	11278-116H9	158.57	24.39	0.48	1.91	0.96	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	65.42	13.31	0.00	2.22	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	98.75	9.42	0.59	2.55	0.20	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	148.73	10.13	6.33	1.58	0.32	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	73.16	10.13	0.56	2.25	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	76.62	11.62	0.13	1.44	0.52	0.52	0.00
Preadipocyte - breast, donor2	11328-117E5	110.55	9.23	4.95	1.58	0.90	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	66.71	8.10	0.85	0.85	0.85	0.32	0.32
Preadipocyte - omental, donor2	11329-117E6	60.67	9.17	0.00	0.87	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	141.53	26.93	1.29	3.44	1.43	0.29	0.43
Preadipocyte - perirenal, donor1	11469-119C2	157.48	9.84	1.97	2.95	1.97	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	93.98	40.54	0.00	9.52	1.84	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	220.82	32.94	2.66	5.49	2.83	1.95	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	219.16	25.03	2.89	4.60	0.68	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	194.12	23.94	0.37	5.12	1.77	1.40	0.65
Preadipocyte - visceral, donor2	11357-117H7	132.53	15.19	1.38	3.22	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	319.74	21.84	2.72	3.76	0.73	0.63	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	162.17	35.30	1.51	4.07	0.91	1.06	0.45
Prostate Epithelial Cells, donor2	11331-117E8	103.86	25.05	2.84	4.60	2.17	0.41	0.95
Prostate Epithelial Cells, donor3	11404-118D9	154.13	15.37	0.86	1.22	0.06	0.80	0.18
Prostate Stromal Cells, donor1	11254-116F3	177.91	27.34	0.46	4.10	0.91	0.80	0.46
Prostate Stromal Cells, donor2	11332-117E9	195.08	22.41	1.79	3.41	1.26	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	134.41	8.13	2.71	1.88	0.21	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	121.17	12.41	0.00	0.36	0.00	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	130.65	7.90	0.97	1.11	0.28	0.28	0.21
Renal Epithelial Cells, donor1	11517-119H5	87.24	18.77	0.00	2.03	0.51	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	177.12	14.23	0.71	3.56	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	103.54	11.33	0.42	1.16	0.32	0.95	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	151.83	16.34	1.36	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	147.30	66.98	1.48	6.33	4.31	0.94	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	164.29	23.53	1.33	5.33	1.11	1.55	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.92	12.64	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	126.11	17.83	0.00	3.96	0.88	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	169.29	10.66	1.25	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	116.51	9.99	0.55	2.22	0.00	0.83	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	187.90	23.35	0.00	2.95	0.54	0.81	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	188.92	9.70	1.27	2.11	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	188.99	15.23	0.39	3.47	0.58	1.74	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	251.76	14.26	1.30	1.56	0.78	1.81	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	126.77	13.08	0.57	1.99	0.85	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	166.72	14.41	1.03	2.06	2.06	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	83.80	7.78	0.25	2.76	0.50	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	93.14	3.21	0.13	0.00	0.13	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	107.21	14.29	0.00	1.79	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	176.12	13.76	0.55	1.10	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	149.07	10.44	0.58	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	124.17	12.48	0.39	3.51	0.78	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	149.55	13.70	2.09	3.48	0.40	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	134.96	17.62	0.56	5.58	1.56	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	209.76	15.38	1.36	2.48	1.61	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	183.91	15.73	1.63	3.73	1.28	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	176.58	11.09	2.08	3.00	0.46	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	154.57	11.77	0.27	1.23	1.10	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	180.47	13.92	4.08	2.87	0.61	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	123.10	20.97	0.18	4.84	1.25	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	182.62	12.91	0.57	1.72	0.57	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	169.23	11.27	2.04	3.22	1.61	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	188.74	15.27	1.77	3.76	1.33	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	148.93	13.19	0.76	0.76	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	147.57	13.32	0.65	2.24	0.93	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	105.42	14.84	0.00	3.38	1.13	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	145.45	10.88	0.13	2.12	1.19	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	146.89	12.07	1.17	3.50	0.49	0.58	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	160.21	13.75	0.38	3.44	0.76	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	147.27	11.00	0.64	0.96	1.39	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	141.83	10.37	2.52	3.08	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	118.26	13.84	0.51	2.73	0.68	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	154.07	10.39	0.18	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	144.71	11.90	0.98	2.94	0.74	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	173.00	17.33	1.61	3.36	0.94	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	180.44	14.39	0.47	1.42	1.65	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	158.73	11.51	1.19	2.38	1.19	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	183.34	15.43	3.74	4.44	0.94	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	199.06	14.51	0.62	0.62	1.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	151.53	7.08	5.53	2.43	1.55	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	146.64	12.32	0.63	3.97	1.04	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	182.63	12.11	0.54	1.75	1.48	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	141.00	11.92	0.51	3.75	0.68	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	153.27	15.42	0.96	5.21	1.54	0.00	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	185.69	17.02	0.52	2.58	1.38	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	144.71	11.80	0.55	2.47	0.96	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	176.65	19.21	3.61	4.10	1.97	0.16	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	151.00	12.61	0.51	0.85	0.68	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	155.95	11.98	0.59	2.81	0.74	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	119.15	11.99	0.53	2.93	0.80	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	121.81	7.74	0.83	1.11	1.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	165.24	10.00	1.43	2.62	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	115.28	7.26	0.20	3.22	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	116.68	7.53	1.51	0.85	0.66	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	112.84	6.29	2.10	4.19	0.00	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	106.08	9.37	0.91	2.42	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	151.88	10.65	0.61	2.08	0.49	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	87.48	13.39	0.58	2.47	0.58	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	126.55	14.60	1.83	3.04	1.83	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	151.30	12.36	0.60	3.01	0.90	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	84.14	9.05	0.68	2.94	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	75.48	11.08	0.60	2.10	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	96.70	14.88	0.71	1.18	0.24	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	97.97	10.67	3.42	2.13	0.85	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	106.37	8.41	3.61	1.80	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	331.76	20.88	2.26	1.88	0.75	1.32	0.38
Schwann Cells, donor2	11578-120F3	146.30	6.80	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	149.41	15.55	3.07	1.75	0.66	0.00	0.44
Sebocyte, donor1	11220-116B5	129.27	32.87	0.00	10.41	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	206.34	24.82	1.84	7.35	1.38	0.92	0.46
Sebocyte, donor3	11378-118B1	177.05	25.56	1.24	5.15	1.44	0.41	0.41
Sertoli Cells, donor1	11255-116F4	115.96	16.57	1.66	0.00	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	454.72	5.65	5.65	2.82	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	116.66	16.54	0.44	3.08	0.26	0.18	0.18
Skeletal Muscle Cells, donor2	11358-117H8	92.52	8.67	0.72	0.00	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	362.84	15.88	3.34	5.02	0.84	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	463.11	28.43	4.08	4.87	1.26	1.89	0.79
Skeletal Muscle Cells, donor5	11455-119A6	416.50	24.08	3.72	4.31	1.49	1.19	0.74
Skeletal Muscle Cells, donor6	11459-119B1	475.25	32.32	2.62	4.46	1.08	2.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	256.04	14.87	1.01	2.65	0.25	0.88	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	230.30	10.56	2.00	2.14	0.71	0.71	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	285.13	33.63	1.69	4.96	0.79	1.09	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	126.46	16.60	0.34	2.27	0.67	0.34	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	177.32	33.29	1.45	8.69	0.00	0.72	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	775.09	12.25	4.54	2.48	0.41	0.28	0.28
Skin - palm, donor1	10286-104F7	110.13	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	174.29	31.28	0.86	5.05	2.16	1.44	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	83.42	137.41	0.82	0.82	0.00	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	165.92	25.06	1.43	5.58	1.82	0.52	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	112.74	19.46	1.95	4.31	0.83	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	101.55	15.33	2.67	3.52	0.56	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	85.64	58.78	0.42	3.38	1.06	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	92.34	14.92	0.82	1.72	0.30	0.45	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	286.67	20.68	5.55	0.93	0.93	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	76.26	12.67	0.89	0.67	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	158.13	24.10	0.59	5.29	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	69.83	20.11	0.44	4.20	0.66	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	146.88	56.31	0.79	12.21	3.94	0.79	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	105.07	17.00	0.77	1.55	1.55	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	85.06	6.00	1.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	99.28	24.35	0.13	6.92	0.67	0.67	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	213.45	24.38	4.21	3.99	2.66	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	365.01	33.29	4.74	8.71	2.82	1.15	1.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	164.42	14.65	1.30	1.63	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	103.36	23.33	0.30	2.95	1.77	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	157.03	16.94	1.57	2.99	0.57	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	170.16	27.65	0.33	2.93	1.14	0.16	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	90.11	6.39	0.91	1.22	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	90.67	16.92	0.25	2.27	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	177.50	12.24	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	215.53	15.74	4.77	4.29	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	173.13	15.78	1.92	2.36	1.18	0.59	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	218.68	15.71	3.66	3.23	0.43	1.08	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	225.55	17.84	3.25	3.99	0.84	0.63	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	181.44	50.89	0.31	12.68	4.18	1.55	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	233.90	42.04	2.16	15.09	6.47	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	227.43	21.52	1.49	3.29	0.90	0.60	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	195.96	28.68	0.34	3.41	0.34	1.37	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	130.44	5.26	0.71	0.94	0.16	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	145.73	19.52	0.20	3.93	1.61	1.41	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	104.90	22.30	0.23	2.28	0.68	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	167.86	14.49	2.42	3.02	1.81	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	372.22	44.77	0.79	9.80	2.91	2.91	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	191.08	12.92	0.13	2.00	0.67	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	176.56	13.40	1.88	2.13	0.63	0.88	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	72.80	4.82	0.51	0.76	0.76	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	377.39	28.50	0.45	6.48	2.56	0.60	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	99.02	12.75	0.75	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	125.34	20.68	12.92	6.46	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	98.59	23.25	0.93	4.19	0.93	0.00	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	162.57	20.20	2.02	9.09	2.52	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	174.87	25.38	2.82	4.70	2.82	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	121.24	14.75	1.18	2.95	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	275.16	25.74	0.17	5.33	1.33	1.33	0.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	109.32	4.20	2.34	0.93	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	190.12	53.39	0.14	11.95	3.45	1.44	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	230.73	30.08	2.80	7.65	2.29	1.27	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	284.49	23.13	3.38	4.14	2.63	0.94	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	198.02	18.17	0.28	1.40	0.42	0.42	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	185.84	16.17	0.42	1.51	0.92	0.42	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	81.43	7.62	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	240.01	48.69	0.00	13.70	3.67	0.98	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	197.31	23.20	0.22	1.10	1.10	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	200.71	9.07	1.46	2.63	0.00	1.46	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	103.59	7.39	0.58	0.97	0.19	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	117.15	10.58	1.59	1.06	1.06	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	216.84	3.35	5.95	0.00	0.37	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	154.51	13.65	2.52	1.80	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	134.57	19.02	1.99	3.41	1.14	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	264.29	21.66	1.58	2.36	2.36	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	154.15	7.36	6.09	2.54	0.00	0.76	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	98.63	1.20	0.80	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	117.46	4.18	2.51	1.67	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	127.88	4.58	2.29	1.38	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	105.20	11.78	0.50	2.19	0.67	0.00	0.67
Synoviocyte, donor2	11368-117I9	96.22	6.37	3.18	0.84	0.00	0.17	0.00
Synoviocyte, donor3	11440-118H9	134.05	3.80	2.23	0.89	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	187.96	30.02	0.00	3.57	1.79	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	61.44	7.93	1.98	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	83.82	9.96	0.00	2.78	0.23	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	172.76	20.65	0.29	3.66	1.15	0.93	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	486.68	35.18	0.77	10.44	1.93	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	150.61	24.05	1.15	4.58	1.72	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	94.48	2.95	0.49	0.25	0.00	0.25	0.12
Urethra, donor2	10319-105A4	39.57	0.00	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	131.50	17.27	0.80	4.25	1.06	0.53	0.00
Urothelial Cells, donor2	11600-120H7	177.85	11.22	0.80	3.61	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	118.04	8.94	2.52	1.60	0.46	0.46	0.00
Urothelial cells, donor0	11216-116B1	151.35	5.80	0.67	0.45	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	96.99	0.00	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	111.51	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	82.83	0.68	0.68	0.68	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	75.75	2.75	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	80.76	1.74	0.58	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	78.09	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	115.64	1.84	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	78.51	1.83	1.83	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	209.47	22.21	1.73	4.69	1.73	0.74	0.49
Wilms' tumor cell line:HFWT	10597-108E3	110.89	14.96	1.76	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	191.61	7.82	1.68	1.12	0.28	0.56	0.00
achilles tendon, donor2	10292-104G4	95.06	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	260.06	27.54	1.02	5.35	1.27	1.02	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	264.21	33.20	0.70	9.29	1.39	0.70	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	110.52	5.34	0.24	0.95	0.24	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	227.76	46.26	1.09	11.70	1.90	1.90	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	413.19	27.27	2.25	4.50	1.12	1.12	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	157.34	16.71	0.63	1.69	0.42	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	81.12	4.36	2.45	1.63	0.54	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	296.11	24.24	3.08	7.49	0.88	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	172.74	21.64	2.86	5.31	1.23	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	257.44	20.19	0.78	6.21	1.55	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	369.66	33.49	2.39	8.46	3.13	3.13	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	269.14	11.70	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	293.96	33.93	2.56	6.04	1.63	0.93	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	335.80	40.39	1.29	9.58	2.07	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	223.57	20.75	3.51	2.63	0.29	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	117.12	11.15	0.00	0.93	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	137.77	13.57	2.88	0.82	0.41	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	256.92	22.41	0.61	9.21	0.61	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	298.27	22.62	0.00	4.27	2.13	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	202.90	18.20	0.30	4.25	1.52	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	237.34	31.77	0.00	5.54	0.96	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	211.38	26.28	1.34	4.45	0.45	3.34	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	229.48	19.68	1.33	2.00	0.33	2.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	265.72	13.01	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	225.62	32.77	2.26	4.52	1.13	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	119.94	8.72	0.44	0.00	0.44	0.87	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	144.33	9.37	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	190.52	12.72	2.35	1.88	0.24	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	58.64	3.26	0.31	0.00	0.00	0.16	0.16
adipose, donor1	10184-103D4	370.02	12.90	6.45	1.17	1.17	2.35	0.59
adipose, donor2	10185-103D5	131.79	3.65	0.81	1.22	0.81	0.41	0.00
adipose, donor3	10186-103D6	171.81	11.71	3.27	2.18	0.82	0.27	0.27
adipose, donor4	10187-103D7	263.49	28.60	0.87	8.67	1.73	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	210.22	14.68	0.79	4.26	1.42	0.79	0.95
adrenal gland, adult, pool1	10081-102A9	145.51	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	138.21	11.74	0.53	1.60	0.00	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	298.35	14.65	0.71	3.93	0.71	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	95.99	2.55	1.16	0.23	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	116.31	4.40	0.68	0.00	0.34	0.34	1.01
amniotic membrane cells, donor3	12237-129G5	117.84	0.59	0.88	0.29	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	56.92	8.30	1.19	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	40.35	3.45	0.41	0.20	0.41	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	60.03	5.16	0.00	0.65	1.94	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	98.30	5.22	0.38	0.51	0.38	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	498.83	54.71	2.21	23.39	4.63	4.41	3.75
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	131.61	9.02	1.34	2.67	1.00	0.67	0.33
aorta, adult, pool1	10052-101G7	88.46	0.59	0.59	0.39	0.20	0.00	0.00
appendix, adult	10189-103D9	116.44	4.27	3.49	0.78	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	145.48	9.63	0.34	2.06	1.03	0.69	0.00
artery, adult	10190-103E1	180.71	0.00	6.79	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	148.78	15.94	0.29	1.16	0.29	0.29	0.29
b cell line:RPMI1788	10427-106D4	158.66	9.22	0.15	2.97	0.15	0.30	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	98.49	14.70	1.66	1.39	0.00	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	173.56	18.66	0.50	3.18	1.39	0.30	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	173.07	30.63	0.84	3.85	0.17	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	233.76	12.30	1.68	2.24	1.12	0.00	0.56
bladder, adult, pool1	10011-101C2	90.50	2.17	0.76	0.22	0.00	0.11	0.11
blood, adult, pool1	10053-101G8	126.23	2.21	8.86	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	167.84	17.13	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	76.26	2.70	2.70	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	61.50	3.08	0.00	2.05	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	51.89	4.57	0.22	0.33	0.45	0.56	0.00
brain, fetal, pool1	10085-102B4	157.61	2.67	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	175.09	5.95	6.28	1.32	0.00	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	55.05	5.87	0.12	0.25	0.12	0.12	0.00
breast, adult, donor1	10080-102A8	129.43	3.79	0.00	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	332.84	18.80	1.65	2.29	0.13	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	209.34	7.73	1.24	1.24	0.00	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	366.28	11.28	4.14	2.99	0.92	2.07	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	191.49	11.38	1.21	2.91	0.24	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	349.33	17.87	0.47	2.35	0.47	0.47	4.23
carcinoid cell line:NCI-H727	10735-110B6	102.05	11.70	0.00	1.75	0.33	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	325.45	19.65	4.75	3.49	1.58	1.27	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	182.60	9.32	3.19	1.33	0.53	0.00	0.53
caudate nucleus - adult, donor10196	10177-103C6	61.02	1.15	1.15	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.02	3.68	0.50	0.50	0.67	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	129.90	3.06	0.00	0.00	2.29	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	89.36	4.03	1.83	0.73	1.10	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	49.53	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	35.87	1.49	0.64	0.00	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	126.25	1.72	1.03	0.34	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	54.80	2.49	0.83	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	103.63	4.79	1.51	0.25	0.25	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	75.28	0.00	2.92	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	125.23	17.25	0.29	1.58	0.43	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	137.38	20.71	0.50	0.83	0.33	0.00	0.50
cervix, adult, pool1	10013-101C4	89.66	2.73	0.84	0.31	0.10	0.10	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	123.59	23.41	0.98	2.09	0.70	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	97.97	5.23	0.00	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	270.05	21.75	1.62	3.60	0.25	0.37	0.25
choriocarcinoma cell line:SCH	10785-110H2	137.14	18.24	1.48	2.09	0.49	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	251.17	17.55	1.90	5.22	0.24	0.71	0.47
chorionic membrane cells, donor1	12238-129G6	79.49	9.69	1.42	0.00	0.28	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	139.10	16.31	0.80	2.09	0.60	0.00	0.20
chorionic membrane cells, donor3	12240-129G8	111.55	6.04	1.65	1.10	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	218.12	27.26	17.17	8.08	1.01	4.04	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	257.41	18.44	0.58	2.88	0.96	0.38	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	147.20	17.11	0.84	3.17	0.84	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	263.73	21.31	0.51	4.62	2.05	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	273.81	21.77	1.21	6.53	1.94	0.97	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	267.54	20.77	1.02	4.68	0.81	1.02	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	513.53	40.63	1.77	7.36	2.06	5.30	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	259.84	29.19	0.26	4.95	0.78	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	482.31	23.77	12.11	2.97	1.37	0.91	0.91
clear cell carcinoma cell line:TEN	10636-108I6	233.37	18.57	2.95	3.82	1.04	0.87	0.87
colon carcinoma cell line:CACO-2	10513-107D9	192.74	27.64	0.18	4.76	1.83	1.28	0.55
colon carcinoma cell line:COLO-320	10420-106C6	310.91	12.92	0.76	4.56	0.00	0.38	2.28
colon, adult, donor1	10082-102B1	121.38	5.95	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	86.72	2.94	0.24	0.12	0.24	0.12	0.00
colon, fetal, donor1	10070-101I7	119.89	0.62	0.62	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	225.33	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	121.53	31.87	0.42	7.65	0.85	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	188.06	39.54	0.30	10.26	1.51	0.91	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	217.02	44.98	0.28	12.13	1.97	0.85	0.85
corpus callosum, adult, pool1	10042-101F6	38.37	2.21	0.00	0.22	0.11	0.22	0.00
cruciate ligament, donor2	10295-104G7	60.79	1.62	1.62	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	163.72	1.61	2.41	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	59.52	3.60	0.48	0.48	0.72	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	323.06	18.37	8.04	2.53	0.00	2.07	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	134.37	25.64	0.51	1.03	0.77	2.05	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	197.63	22.15	0.96	6.50	0.96	1.20	0.72
ductus deferens, adult	10196-103E7	78.74	1.99	0.50	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	155.54	1.44	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	104.46	2.21	3.68	0.00	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	71.85	3.30	0.00	0.58	0.17	0.08	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	164.56	114.59	1.11	32.20	26.87	5.55	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	359.95	74.66	2.01	20.63	10.89	5.88	2.87
embryonic pancreas cell line:1B2C6	10604-108F1	174.50	17.88	4.32	1.23	0.00	1.23	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	177.69	15.74	6.66	2.72	0.61	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	200.38	21.92	0.93	2.16	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	300.78	23.64	2.63	5.25	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	408.27	98.21	1.01	27.15	1.34	1.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	104.39	7.25	0.54	1.63	0.00	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	160.33	31.36	3.86	4.18	0.80	0.64	0.80
epidermoid carcinoma cell line:A431	10426-106D3	198.42	17.79	0.33	2.22	0.22	1.11	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	167.07	21.45	0.99	3.74	0.33	1.76	0.55
epididymis, adult	10197-103E8	92.72	2.30	4.19	0.00	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	152.57	9.05	0.35	0.71	0.71	0.89	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	179.71	17.30	1.18	3.15	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	230.78	31.19	2.23	7.73	2.75	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	170.07	24.61	0.98	3.94	1.18	0.79	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	259.80	42.80	1.12	7.73	2.13	1.90	0.56
esophagus, adult, pool1	10015-101C6	92.16	4.99	0.85	0.42	0.00	0.00	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	179.21	12.40	0.13	1.75	0.50	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	36.22	2.41	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	63.13	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	37.21	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	57.32	2.29	0.00	0.00	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	81.61	5.83	4.37	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	105.25	1.27	0.51	0.00	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	276.20	29.36	1.15	6.92	1.03	0.64	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	395.07	42.97	1.66	10.45	4.51	2.14	0.71
frontal lobe, adult, pool1	10040-101F4	52.45	4.32	0.00	0.19	0.56	0.38	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	104.49	15.61	0.00	2.10	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	159.37	10.42	0.18	2.19	0.09	0.27	0.27
gall bladder, adult	10198-103E9	86.67	5.07	2.17	0.48	0.00	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	164.81	4.83	1.61	0.54	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	117.65	4.11	1.12	0.37	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	258.74	49.42	5.07	8.87	2.11	1.27	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	294.57	17.41	2.32	2.32	0.39	1.16	0.39
gastric cancer cell line:AZ521	10549-107H9	196.25	37.22	0.16	8.36	2.95	0.82	0.66
gastric cancer cell line:GSS	10560-108A2	262.67	6.41	2.75	0.92	0.92	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	99.38	19.42	2.51	2.28	0.23	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	230.97	33.16	1.26	4.82	0.80	1.15	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	182.65	6.16	0.56	0.28	0.14	0.98	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	148.65	11.97	1.50	2.00	0.50	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	115.47	11.51	0.11	1.69	0.21	0.53	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	154.76	13.48	0.42	1.54	0.28	0.70	0.42
glioblastoma cell line:T98G	10485-107A8	164.90	13.02	0.44	1.77	0.77	1.43	1.21
glioma cell line:GI-1	10413-106B8	130.62	12.30	0.29	3.81	0.29	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	68.52	4.37	0.00	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	53.46	4.64	0.73	0.00	0.24	0.00	0.98
globus pallidus, adult, donor10258	10367-105F7	110.91	0.00	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	76.21	11.19	1.07	0.53	2.13	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	7.34	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	219.52	31.36	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	96.96	5.76	1.92	0.64	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	433.86	49.58	0.92	10.10	5.97	3.67	1.84
hIPS +CCl2, biol_rep2	14384-156C1	304.99	44.35	3.66	13.72	5.03	0.91	2.74
hIPS +CCl2, biol_rep3	14385-156C2	476.63	59.26	2.58	19.97	4.51	2.58	1.93
hIPS, biol_rep1	14380-156B6	169.60	58.93	0.00	12.94	4.31	7.19	2.87
hIPS, biol_rep2	14381-156B7	337.45	72.02	1.37	30.86	3.43	3.43	3.43
hIPS, biol_rep3	14382-156B8	90.48	17.66	0.00	2.21	3.31	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	214.65	14.37	1.15	3.74	0.00	0.86	0.86
heart - mitral valve, adult	10205-103F7	70.56	1.20	1.49	0.00	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	75.57	0.78	0.78	0.00	0.00	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	86.59	9.99	0.83	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	91.62	7.55	1.22	0.61	1.02	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	79.63	2.13	0.85	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	78.42	2.76	0.92	0.00	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	76.39	3.49	0.21	0.10	0.10	0.41	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	124.03	7.10	1.23	0.93	0.00	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	191.46	9.51	2.38	2.38	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	233.81	46.30	1.22	9.61	5.41	0.66	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	237.29	47.94	1.70	8.74	5.83	1.09	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	226.36	47.09	1.82	9.50	5.96	0.51	0.20
hepatoma cell line:Li-7	10484-107A7	186.40	23.69	0.22	3.34	1.22	1.45	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	345.92	39.80	0.60	11.76	2.11	1.41	0.80
hippocampus - adult, donor10196	10169-103B7	70.03	6.62	0.00	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	42.45	1.63	1.02	0.00	0.20	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	60.75	4.48	0.00	0.00	1.49	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	62.39	8.46	0.70	1.06	0.70	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	927.72	96.43	29.91	29.30	10.38	7.93	4.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	365.02	63.62	3.14	21.40	3.34	2.55	2.95
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	451.43	76.42	8.12	23.10	4.06	3.05	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	213.70	13.53	1.69	3.38	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	280.16	9.30	19.11	2.84	0.26	0.77	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	219.03	16.32	8.73	2.66	0.00	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	184.22	11.39	4.96	1.46	0.88	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	150.80	7.11	4.95	1.51	0.22	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	167.66	12.10	1.67	2.09	0.83	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	152.97	20.13	1.18	4.74	0.47	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	202.18	13.98	4.18	2.73	1.13	0.64	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	123.21	18.18	0.67	4.71	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	344.42	60.40	3.44	18.15	2.19	1.41	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	472.62	78.12	21.13	16.70	5.90	2.95	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	775.88	70.69	7.85	23.56	6.11	6.11	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	163.23	8.59	3.25	2.48	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	165.71	10.90	4.36	1.31	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	309.85	10.99	15.49	2.00	1.00	0.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	135.27	4.90	2.64	0.94	0.19	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	148.24	9.55	4.55	1.36	0.45	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	177.60	3.45	3.76	0.31	0.00	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	144.69	11.76	2.29	1.63	0.33	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	138.48	9.87	3.48	0.58	0.58	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	189.52	16.74	4.48	1.49	0.90	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	338.64	60.60	4.62	19.21	3.69	2.22	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	338.35	62.48	3.42	13.98	2.57	2.85	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	655.75	92.69	6.94	27.36	5.31	2.04	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	233.08	13.38	7.04	4.22	0.35	1.06	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	159.00	12.04	2.85	1.58	0.63	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	174.91	16.04	3.63	3.33	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	134.97	5.69	1.55	0.52	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	133.50	5.31	1.99	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	148.53	6.67	4.10	0.51	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	171.28	17.90	3.07	4.35	1.28	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	156.75	13.63	5.30	2.27	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	238.26	23.86	4.03	3.70	1.01	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	367.33	61.58	5.80	12.32	2.42	1.93	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	523.65	74.43	10.70	21.39	5.79	2.23	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	480.98	63.90	6.83	21.46	2.93	1.46	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	129.58	7.33	2.75	2.14	0.61	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	949.95	19.52	16.27	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	297.52	15.22	8.60	2.32	0.33	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	114.93	8.21	3.28	1.09	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	164.66	11.94	2.90	1.81	1.09	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	141.99	7.83	2.14	1.07	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	124.11	5.97	0.00	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	115.79	18.28	1.08	1.90	1.08	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	214.44	14.28	2.16	4.31	0.27	0.81	0.27
immature langerhans cells, donor1	11904-125F5	129.31	3.15	0.48	0.48	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	108.52	2.38	2.38	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	47.41	3.97	0.09	0.09	0.57	0.09	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	248.09	40.64	1.30	4.55	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	82.81	6.51	0.30	0.70	0.20	0.30	0.10
kidney, fetal, pool1	10045-101F9	50.72	2.12	0.14	0.14	0.00	0.07	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	218.85	51.27	0.85	8.38	0.43	0.57	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	218.56	20.74	3.87	7.19	0.55	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	221.67	13.76	0.55	3.12	0.73	0.92	0.55
left atrium, adult, donor1	10079-102A7	134.58	1.63	2.18	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	132.48	1.52	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	345.02	19.15	1.37	5.47	2.19	0.82	0.27
leiomyoma cell line:10964C	10569-108B2	144.06	11.14	5.39	2.16	2.51	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	122.28	18.48	3.26	3.26	3.80	1.63	0.54
leiomyoma cell line:15425	10571-108B4	155.40	14.81	4.13	2.43	1.46	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	6.35	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	129.65	12.55	3.14	3.14	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	221.00	25.85	0.83	6.14	1.89	0.83	0.47
liposarcoma cell line:KMLS-1	10782-110G8	154.18	9.53	2.34	1.87	0.78	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	177.76	8.53	0.97	2.07	1.10	0.49	0.37
liver, adult, pool1	10018-101C9	99.34	10.37	0.49	1.46	0.00	0.32	0.00
liver, fetal, pool1	10086-102B5	86.55	1.88	1.88	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	40.83	2.04	0.00	0.29	0.73	0.15	0.58
locus coeruleus, adult, donor10252	10165-103B3	51.86	3.51	0.74	0.74	0.18	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	80.97	3.95	1.69	1.97	0.28	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	107.68	9.67	2.52	1.68	1.26	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	98.12	11.35	0.28	1.94	0.69	0.55	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	160.63	9.65	0.00	2.07	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	207.35	14.37	1.58	5.01	0.79	0.00	0.00
lung, adult, pool1	10019-101D1	71.94	2.01	0.59	0.24	0.00	0.00	0.00
lung, fetal, donor1	10068-101I5	90.47	2.00	0.29	0.29	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	149.38	2.29	3.67	0.92	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	203.55	2.84	1.42	0.95	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	194.41	8.33	1.75	2.41	0.22	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	153.04	13.58	0.75	2.11	0.30	0.75	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	64.56	30.58	0.00	0.85	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	46.17	4.00	0.00	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	47.11	3.11	0.21	0.42	0.00	0.21	0.62
mature adipocyte, donor3	12233-129G1	47.65	2.37	0.47	0.24	0.00	0.24	0.47
mature adipocyte, donor4	12234-129G2	58.43	2.37	0.79	0.53	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	149.39	14.77	0.48	2.62	0.95	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	66.55	4.51	0.00	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	37.52	2.21	0.00	0.55	0.55	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	97.85	2.54	0.64	0.00	1.91	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	117.71	3.41	2.56	0.43	1.71	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	78.81	3.71	2.03	0.51	1.86	0.51	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	37.35	3.18	0.85	0.21	0.21	0.42	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	36.60	7.71	0.00	0.00	1.93	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	56.35	4.67	0.00	1.08	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	79.18	1.95	0.00	0.00	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	37.15	2.63	0.31	0.00	0.46	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	33.06	2.69	0.08	0.24	0.24	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	63.88	5.90	0.35	1.04	0.35	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	329.02	27.01	4.43	5.54	1.11	2.66	1.11
medulloblastoma cell line:ONS-76	10759-110E3	263.50	25.31	0.73	4.77	1.22	1.59	0.73
melanoma cell line:COLO 679	10514-107E1	121.03	41.11	0.14	8.19	2.73	1.01	0.29
melanoma cell line:G-361	10465-106H6	223.69	32.03	1.36	7.60	2.44	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	170.77	20.62	9.95	3.80	0.18	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	143.63	7.93	5.29	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	212.04	22.29	2.33	2.85	1.30	1.04	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	303.19	21.17	2.45	4.45	0.77	0.92	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	152.33	8.36	1.27	1.27	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	193.80	14.49	1.66	2.07	1.24	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	123.48	5.76	0.70	0.98	0.14	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	154.82	7.13	0.96	0.96	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	83.29	4.86	0.69	1.39	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	155.50	6.69	1.20	1.03	0.34	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	144.57	9.32	1.38	1.73	0.58	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	200.28	15.39	0.93	2.12	0.66	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	176.63	22.01	1.22	2.84	0.41	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	146.39	15.65	0.71	2.13	0.43	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	87.28	7.25	0.33	0.66	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	171.72	13.70	0.28	0.97	0.83	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	143.82	16.06	1.75	1.75	0.35	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	162.92	8.98	1.02	1.22	0.41	0.41	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	80.52	9.71	1.44	3.24	2.16	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	114.73	4.24	0.93	0.31	0.10	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	90.28	12.54	1.14	1.60	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	219.01	28.11	0.84	3.78	3.36	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	165.43	12.70	0.90	1.49	0.60	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	136.99	9.19	0.44	1.49	0.79	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	85.04	2.95	2.21	0.37	0.00	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	99.87	8.01	0.57	1.72	0.86	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	202.09	17.68	8.00	1.68	0.84	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	153.44	7.76	0.91	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	120.47	9.21	1.02	1.28	0.51	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	101.56	11.78	0.52	1.83	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	93.04	6.78	1.23	1.23	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	102.14	8.24	2.35	1.88	0.71	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	101.54	7.78	1.02	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	100.60	7.86	1.57	1.57	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	110.75	7.41	1.39	0.93	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	148.25	9.52	1.73	0.87	0.00	1.15	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	88.79	8.48	0.89	2.23	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	96.62	7.21	0.72	1.20	0.48	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	111.47	9.53	3.67	0.73	0.73	0.00	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	100.36	9.73	1.01	1.01	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	100.71	9.42	0.41	2.46	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	99.66	9.45	1.29	1.72	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	106.64	10.94	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	10.33	15.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	159.79	10.72	7.79	2.27	0.00	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	148.41	8.73	4.36	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	183.38	9.60	9.60	2.13	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	143.93	10.63	8.18	1.64	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	138.38	8.94	5.05	1.94	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	115.43	6.30	8.39	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	141.07	14.90	5.96	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	133.48	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	128.08	3.56	5.34	2.37	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	136.47	9.75	3.66	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	185.58	8.87	5.07	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	158.31	7.93	5.52	0.69	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	85.97	12.90	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	103.79	11.98	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	123.98	20.66	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	129.17	12.63	1.63	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	140.62	12.71	3.97	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	118.49	17.69	4.13	1.77	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	111.59	17.46	4.36	1.87	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	92.23	8.02	5.35	6.68	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	138.37	29.57	3.55	4.73	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	177.19	41.09	7.70	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	182.43	20.65	1.38	4.13	0.69	0.69	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	200.40	22.27	3.96	5.44	0.49	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	170.47	22.43	2.24	3.36	2.24	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	182.55	20.99	5.09	2.54	1.27	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	167.64	12.90	2.82	2.42	0.81	1.21	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	152.64	17.44	0.00	0.00	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	146.98	13.94	2.53	5.07	0.00	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	112.88	3.64	1.21	0.00	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	158.16	4.52	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	116.96	5.77	3.29	0.82	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	135.33	18.06	0.99	1.79	0.60	0.79	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	158.68	14.93	4.54	1.62	0.32	0.97	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	121.22	13.24	2.04	0.00	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	90.52	8.51	0.00	3.09	3.87	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	212.14	18.66	1.18	5.20	0.24	0.71	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	132.29	16.91	0.46	1.62	0.93	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	205.13	34.19	0.00	17.09	8.55	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	406.89	87.34	1.54	25.69	12.74	5.55	2.67
mesothelioma cell line:Mero-25	10850-111F4	132.54	21.56	1.13	3.18	1.36	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	201.45	13.45	1.47	1.71	0.24	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	220.10	23.25	0.89	6.86	1.77	1.11	0.89
mesothelioma cell line:Mero-82	10853-111F7	154.79	40.47	1.31	8.94	2.37	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	195.41	26.38	1.02	5.96	2.72	1.19	0.51
mesothelioma cell line:Mero-84	10855-111F9	182.25	17.95	1.01	3.03	1.77	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	117.60	10.35	1.24	1.24	0.41	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	160.18	17.56	0.50	2.65	0.83	1.49	0.66
mesothelioma cell line:NCI-H226	10846-111E9	211.04	29.50	1.09	11.76	7.42	1.09	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	186.71	19.30	0.85	2.39	0.68	0.85	0.51
mesothelioma cell line:NCI-H28	10845-111E8	158.53	11.71	1.78	1.78	0.25	0.25	0.51
mesothelioma cell line:No36	10857-111G2	207.46	20.88	1.63	4.89	1.63	1.63	0.65
mesothelioma cell line:ONE58	10858-111G3	114.34	11.92	1.63	1.35	1.90	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	74.27	0.38	0.58	0.00	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	46.04	0.73	0.37	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	101.05	1.62	0.54	0.18	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	137.77	20.24	5.22	2.29	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	229.10	30.52	4.45	8.05	0.21	1.06	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	209.63	25.80	0.46	5.99	0.46	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	173.93	7.04	0.95	2.47	0.19	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	242.63	42.32	3.14	7.39	1.11	1.11	1.11
myeloma cell line:PCM6	10474-106I6	126.70	18.98	0.40	5.14	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	165.38	13.70	2.03	1.52	0.51	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	132.20	7.65	0.20	1.18	0.00	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	177.17	19.72	0.67	2.23	0.00	0.67	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	178.78	20.08	1.10	2.50	0.15	0.66	0.22
nasal epithelial cells, donor2	12227-129F4	69.00	10.49	1.66	1.10	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	423.54	31.75	1.15	10.35	0.92	1.84	0.46
neuroblastoma cell line:NB-1	10539-107G8	204.67	15.90	0.37	3.37	0.19	1.12	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	161.75	34.80	1.05	5.48	0.21	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	451.53	19.57	2.05	4.47	0.00	1.12	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	123.12	4.51	3.32	0.24	0.00	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	197.18	9.98	3.96	1.74	0.00	0.48	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	304.10	17.71	1.21	2.01	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	207.26	8.90	1.27	3.18	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	155.71	17.03	0.53	1.86	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	142.06	9.47	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	118.38	6.93	0.51	1.86	0.00	0.17	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	267.37	31.22	0.80	9.61	0.00	1.60	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	202.62	8.34	4.81	2.24	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	123.76	11.30	4.73	1.31	0.79	0.53	0.26
nucleus accumbens, adult, pool1	10037-101F1	42.93	3.56	0.09	0.09	0.75	0.28	0.19
occipital cortex - adult, donor10196	10172-103C1	63.87	4.12	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	31.94	2.15	0.27	0.00	0.00	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	50.95	2.91	0.36	0.73	1.09	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	97.61	1.57	1.05	0.52	2.36	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	212.83	1.72	4.29	0.43	0.86	0.43	0.00
occipital pole, adult, pool1	10036-101E9	28.30	2.76	0.00	0.24	0.55	0.24	0.39
olfactory region, adult	10195-103E6	53.11	1.91	0.76	0.96	0.19	0.19	0.57
optic nerve, donor1	10277-104E7	42.02	6.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.26	14.69	0.23	2.96	0.57	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	143.02	12.64	0.41	1.51	0.55	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	134.78	14.05	9.82	2.54	0.51	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	222.70	20.68	1.50	5.08	0.46	0.69	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	98.18	4.70	0.59	0.59	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	306.46	45.78	0.00	6.54	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	122.78	16.75	0.21	3.18	0.64	1.27	0.85
ovary, adult, pool1	10020-101D2	123.34	4.63	0.00	0.96	0.09	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	207.52	18.52	0.73	6.05	0.92	0.37	0.55
pancreas, adult, donor1	10049-101G4	194.71	0.94	4.70	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	165.76	10.06	1.12	1.40	1.40	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	170.18	21.12	8.52	2.90	1.36	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	145.38	8.61	0.33	0.99	0.00	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	41.92	3.84	0.00	0.55	0.46	0.27	0.00
parietal cortex, adult, donor10258	10373-105G4	49.18	0.00	0.73	2.20	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	61.13	1.88	1.88	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	28.50	0.86	0.29	0.29	0.00	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	38.51	3.44	0.00	0.18	0.18	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	226.94	0.97	0.97	0.00	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	62.43	4.49	1.12	1.12	1.12	0.37	0.00
parotid gland, adult	10199-103F1	174.52	0.62	3.70	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	90.23	0.00	1.61	0.00	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	168.64	7.44	2.60	0.74	0.19	0.93	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	102.86	5.97	1.17	0.73	0.15	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	41.93	3.87	0.00	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	45.60	0.59	0.00	0.00	0.59	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	95.32	2.51	1.25	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	128.50	4.05	2.02	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	94.33	4.17	0.52	0.52	0.00	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	179.61	1.70	0.00	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	84.07	3.23	0.00	0.54	0.00	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	228.57	12.05	1.06	4.50	0.26	0.53	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	65.37	3.27	0.47	0.47	0.00	0.16	0.31
pons, adult, pool1	10033-101E6	35.12	3.53	0.09	0.26	0.43	0.26	0.34
postcentral gyrus, adult, pool1	10032-101E5	44.90	4.01	0.09	0.44	0.61	0.35	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	29.28	14.64	0.00	4.18	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	187.27	27.54	11.02	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	176.04	35.21	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	254.47	18.21	1.02	4.08	1.17	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	149.19	15.79	0.18	2.36	0.00	2.18	0.91
prostate, adult, pool1	10022-101D4	71.83	2.99	0.63	0.27	0.00	0.18	0.09
putamen, adult, donor10196	10176-103C5	56.66	3.30	0.47	0.00	0.47	0.24	0.24
putamen, adult, donor10252	10152-102I8	58.82	7.84	0.00	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	145.34	10.93	0.00	3.28	1.09	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	43.97	4.59	0.00	0.00	0.72	0.48	0.48
putamen, newborn, donor10223	10365-105F5	95.21	6.00	0.75	0.00	1.50	1.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	128.88	8.73	0.00	1.16	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	200.30	2.78	2.78	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	146.28	8.48	0.21	1.27	0.64	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	69.17	0.41	1.24	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	60.63	2.19	0.10	0.10	0.10	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	216.93	9.87	0.78	3.38	0.52	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	184.67	18.32	0.98	2.58	0.98	0.74	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	306.79	22.21	0.00	3.09	0.00	2.25	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	171.28	5.30	0.00	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	129.97	8.74	0.81	1.62	0.16	0.32	0.00
salivary acinar cells, donor2	11772-123I8	97.62	6.06	1.93	1.10	0.28	0.00	0.00
salivary acinar cells, donor3	11773-123I9	102.62	3.31	0.66	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	140.70	1.14	0.00	0.57	0.57	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	90.04	9.95	0.25	1.43	0.08	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	135.42	10.70	0.71	2.23	0.35	0.35	0.00
seminal vesicle, adult	10201-103F3	91.53	0.00	4.23	0.00	0.53	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	100.57	16.52	4.37	1.70	0.24	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	97.63	4.78	3.52	0.25	0.00	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	175.62	12.04	0.00	2.01	0.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	121.69	17.06	1.07	1.88	0.94	0.54	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	98.59	14.81	0.44	1.22	0.00	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	211.47	29.80	0.65	5.81	2.58	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	141.16	2.13	0.71	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	130.97	4.56	0.36	0.72	0.12	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	253.26	0.00	2.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	142.49	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	159.07	1.26	5.68	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	207.12	31.02	1.00	2.67	0.33	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	133.33	8.83	3.47	1.26	0.32	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	297.22	12.14	4.24	1.16	0.58	0.39	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	235.21	20.27	1.15	3.63	0.49	0.66	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	170.82	2.57	1.45	1.93	0.16	1.77	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	105.91	13.08	0.00	1.09	1.09	0.00	0.00
small intestine, adult, pool1	10024-101D6	75.37	2.51	0.00	0.24	0.12	0.12	0.00
small intestine, fetal, donor1	10064-101I1	147.66	3.44	2.70	0.25	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	54.88	4.62	3.59	0.00	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	80.90	0.52	1.81	0.00	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	150.63	16.62	1.07	1.34	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	59.19	1.84	1.61	0.46	0.00	0.00	0.46
spinal cord, adult, donor10252	10159-103A6	40.61	1.58	0.00	0.79	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	90.63	2.77	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	106.72	3.66	1.83	1.22	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	120.31	6.43	0.92	0.46	0.00	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	138.45	14.04	1.19	1.94	0.60	0.00	0.15
spleen, adult, pool1	10025-101D7	75.44	6.72	0.66	0.99	0.22	0.22	0.11
spleen, fetal, pool1	10044-101F8	46.64	3.34	0.08	0.79	0.00	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	166.76	10.56	0.72	0.93	0.00	0.83	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	159.69	19.75	0.76	3.23	0.19	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	91.56	6.29	2.10	1.75	0.00	1.40	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	187.26	23.46	5.86	4.30	2.35	1.95	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	218.59	30.84	0.34	3.94	0.90	1.69	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	766.30	38.55	5.51	11.01	1.27	5.93	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	156.96	16.08	0.42	5.92	2.12	1.27	0.00
stomach, fetal, donor1	10062-101H8	217.87	4.27	3.20	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	116.78	2.28	6.27	0.00	0.00	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	43.20	2.91	0.83	0.00	0.00	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	50.17	3.10	0.52	1.03	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	59.35	2.12	0.71	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	257.92	26.59	1.38	5.27	1.83	1.15	1.60
temporal lobe, adult, pool1	10031-101E4	45.27	3.81	0.08	0.34	0.51	0.17	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	163.82	3.56	3.56	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	130.54	1.32	5.27	0.00	0.00	0.44	0.44
tenocyte, donor1	11763-123H8	131.61	12.92	3.14	0.35	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	82.02	9.16	0.38	0.38	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	117.87	9.64	2.59	1.11	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	360.32	43.51	3.40	15.30	7.99	2.04	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	291.65	27.13	3.70	6.47	0.92	1.54	0.46
teratocarcinoma cell line:PA-1	10807-111A6	294.46	16.89	1.86	4.80	0.00	0.62	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	210.35	34.40	1.65	13.58	2.29	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	224.26	35.17	1.13	5.29	0.76	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	258.04	17.67	1.85	3.60	0.65	2.07	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	213.99	48.53	6.19	5.54	0.65	0.98	0.65
testis, adult, pool1	10026-101D8	62.81	4.08	0.54	0.54	0.00	0.86	0.11
testis, adult, pool2	10096-102C6	68.56	3.16	1.35	0.45	0.00	0.90	0.00
thalamus - adult, donor10196	10168-103B6	65.14	1.10	0.00	0.00	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	39.07	1.56	0.47	0.16	0.16	0.00	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	1.54	0.00	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	74.60	2.31	0.33	0.16	0.49	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	64.44	6.90	1.73	0.58	1.15	0.58	0.00
throat, adult	10209-103G2	108.86	2.50	4.24	0.00	0.00	0.00	0.00
throat, fetal, donor1	10061-101H7	134.07	2.13	2.13	0.30	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	197.14	19.67	0.60	3.78	0.79	1.79	1.99
thymus, adult, pool1	10027-101D9	84.40	4.57	0.60	0.99	0.10	0.00	0.20
thymus, fetal, pool1	10043-101F7	62.03	3.22	0.10	0.31	0.21	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	283.47	19.94	1.20	3.86	1.33	0.80	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	291.81	19.98	1.40	5.03	1.26	0.84	0.00
thyroid, adult, pool1	10028-101E1	89.11	2.99	0.56	0.19	0.00	0.09	0.19
thyroid, fetal, donor1	10060-101H6	91.75	0.79	2.11	0.00	0.00	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	3.08	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	146.99	6.28	4.65	2.09	0.23	0.93	0.23
tongue, fetal, donor1	10059-101H5	186.01	4.34	3.15	0.00	0.00	0.39	0.39
tonsil, adult, pool1	10047-101G2	83.45	6.31	0.40	1.00	0.10	0.20	0.20
trachea, adult, pool1	10029-101E2	70.76	7.28	0.49	1.64	0.08	0.08	0.08
trachea, fetal, donor1	10058-101H4	115.02	3.85	2.69	0.00	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	395.73	20.90	1.42	7.79	0.00	0.00	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	160.79	12.46	0.10	2.63	0.71	0.51	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	215.91	14.42	1.88	2.51	0.00	0.63	0.16
tridermal teratoma cell line:HGRT	10694-109G1	264.45	1.90	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	180.90	8.97	1.19	2.20	0.68	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	73.03	8.35	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	79.00	1.71	0.17	0.17	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	143.85	2.05	2.56	1.02	0.00	0.00	0.00
vagina, adult	10204-103F6	69.79	1.29	1.94	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	84.83	1.97	4.60	0.44	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	198.41	5.87	1.60	2.14	0.00	0.80	0.53

Property "Nearest transcripts" (as page type) with input value "ENST00000587478.1:97 ENST00000593262.1:97 ENST00000253788.12:97 NM_000988.5:97 NM_001349922.2:97 NR_146327.2:97 AK124148:97 BC098560:112 ENST00000588830.1:114 AK311792:116 BC002588:127 ENST00000589913.6:149 ENST00000590864.2:368 FJ655906:421 L05094:421 L19527:421 DQ895779:429 KJ892035:429 DQ892563:429 KJ904552:462 BC021886:462 ENST00000586277.5:487" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.